Falco Closes $7 Million Financing with Osisko Not for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
48
Falco Closes $7 Million Financing with Osisko

Not for Dissemination in the United States or through US Newswire Services

MONTREAL, July 03, 2018 (GLOBE NEWSWIRE) -- Falco Resources Ltd. (TSX-V: FPC ) (“Falco” or the “Company”) is pleased to announce that it has closed its previously announced $7 million financing transaction (the “Debenture Financing”) with Osisko Gold Royalties Ltd (TSX: OR ) (NYSE: OR ) (“Osisko”). Under the terms of the Debenture Financing, Osisko purchased a secured debenture (the “Debenture”) having a principal amount of $7,000,000 (the “Principal”). The Company shall use the net proceeds received under the Debenture for the development, construction and working capital requirements of the Horne 5 Property.

Upon receipt of disinterested shareholder approval, the Debenture is convertible (the “Conversion”) into units of Falco (the “Units”).  There will be no interest payable at any time on the outstanding Principal of the Debenture unless Falco fails to obtain disinterested shareholder approval for the Conversion, in which case interest shall accrue retroactively from the closing date of the Debenture Financing at a rate per annum that is equal to 7%, compounded quarterly. Accrued interest shall be payable upon repayment of the Principal when due, as per the terms of the Debenture. The maturity date of the Debenture shall be the earlier of (i) the date of the meeting of the Falco shareholders to be held to obtain the disinterested shareholder approval and (ii) December 31 st , 2018, subject to extension in accordance with the terms of the Debenture.

On the date upon which Falco obtains the disinterested shareholder approval for the Conversion, the Debenture shall be converted into 12,104,444 Units of Falco. Each Unit shall consist of one common share of Falco (“Common Shares”) and one-half of one common share purchase warrant. Each whole warrant shall entitle the holder to purchase one Common Share, subject to customary anti-dilution clauses, at a price of $0.75 for a period of thirty-six (36) months from the date the Units are issued.

The Units, if issued following receipt of the disinterested shareholder approval, will be subject to a hold period of four months from the date of Conversion in accordance with applicable Canadian securities laws.

The Debenture Financing is considered to be a “related party transaction” under Regulation 61-101 respecting Protection of Minority Security Holders in Special Transactions (“Regulation 61-101”). The Debenture Financing is exempt from the requirements to obtain a formal valuation pursuant to section 5.5(b) of Regulation 61-101, as the Common Shares are not listed on any of the specified markets. The Conversion of the Debenture is subject to receipt of disinterested shareholder approval. Without the Conversion feature, the Debenture Financing is exempt from disinterested shareholder approval pursuant to section 5.7(1)(f) of Regulation 61-101, as the Debenture, at the time of closing, (i) is not convertible, directly or indirectly, into equity or voting securities of the Company or a subsidiary of the Company, and (ii) is on reasonable commercial terms that are not less advantageous to the Company than if the Debenture was obtained from an arm's length party.  The special meeting of shareholders to obtain the disinterested shareholder approval for the Conversion of the Debenture is expected to occur at the end of September 2018.

For greater clarity, the Debenture shall only become convertible if the shareholders of Falco approve both the Conversion and the previously announced silver stream transaction with Osisko. At the meeting, the shareholders will also be asked to approve a waiver of the application of the Shareholder Rights Plan of the Company should, as a result of the Conversion, Osisko become the beneficial owner of more than 20% of the issued and outstanding Common Shares on a partially diluted basis assuming exercise of the warrants then held by Osisko. 

Concurrently with the signing of the Debenture, Falco and Osisko have entered into an investor rights agreement (the “Investor Rights Agreement”) in favor of Osisko granting Osisko, so long as Osisko holds a minimum of 5% of the issued and outstanding Common Shares of Falco, i) a contractual right to participate in future equity or equity-linked offerings by Falco to maintain its pro rata ownership interest in Falco at the time of Conversion and ii) a right to designate two individuals for election to the board of directors of Falco. In addition, the Investor Rights Agreement provides that, so long as Osisko holds a minimum of 10% of the issued and outstanding Common Shares of Falco, Osisko shall have customary demand and piggyback registration rights with respect to the registration of sales of Common Shares owned by Osisko. Osisko’s initial representatives on the board of directors of Falco under the Investor Right Agreement are current directors Sean Roosen and Bryan A. Coates.

About Falco

Falco Resources Ltd. is one of the largest mineral claim holders in the Province of Québec, with extensive land holdings in the Abitibi Greenstone Belt. Falco owns about 67,000 hectares of land in the Rouyn-Noranda mining camp, which represents approximately 70% of the entire camp and includes 13 former gold and base metal mine sites. Falco's principal asset is the Horne 5 Project located in the former Horne mine that was operated by Noranda from 1927 to 1976 and produced 11.6 million ounces of gold and 2.5 billion pounds of copper. Osisko is the largest shareholder of the Company and currently owns 13.2% of the issued and outstanding shares of the Company. The Company has 180,620,244 shares issued and outstanding.

For further information contact: Vincent Metcalfe Chief Financial Officer 514-905-3162 info@falcores.com    

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Cautionary Note Regarding Forward-Looking Statements

This news release contains forward-looking statements and forward-looking information (together, “forward-looking statements”) within the meaning of applicable securities laws. All statements, other than statements of historical facts, are forward-looking statements, and subject to risks and uncertainties. Generally, forward-looking statements can be identified by the use of terminology such as “plans”, “seeks”, “expects”, “estimates”, “intends”, “anticipates”, “believes”, “could”, “might”, “likely” or variations of such words, or statements that certain actions, events or results “may”, “will”, “could”, “would”, “might”, “will be taken”, “occur”, “be achieved” or other similar expressions. Forward-looking statements, including statements concerning the Conversion of the Debenture, obtaining disinterested shareholder approval, and the Company’s use of proceeds from the Debenture Financing, involve risks, uncertainties and other factors that could cause actual results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements are subject to business and economic factors and uncertainties, and other factors that could cause actual results to differ materially from these forward-looking statements, including the obtaining of all required authorizations from third parties on terms acceptable to the Company and in a timely manner and those risks set out in Falco's public documents, including in each management discussion and analysis, filed on SEDAR at www.sedar.com. Furthermore, should one or more of the risks, uncertainties or other factors materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking statements or information. These risks, uncertainties and other factors include, among others, political, economic, environmental and permitting risks, regulatory restrictions, mining operational and development risks, litigation risks, regulatory restrictions, environmental and permitting restrictions and liabilities, internal and external approval risks, changes in the use of proceeds relating to the Debenture Fi nancing , currency fluctuations, global economic climate,  dilution, share price volatility, competition, loss of key employees, additional funding requirements, and defective title to mineral claims or property . Although Falco believes that the assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur in the disclosed times frames or at all. Except where required by applicable law, Falco disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 595

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 102

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 21

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 193

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 550

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 28

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 116

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading

Top 5 Most Recently Viewed Articles

Buena Vida y Salud ACO Celebrated for Value-Based Care Innovation

Updated Category News Views 120

Buena Vida y Salud ACO Achieves National Recognition Buena Vida y Salud ACO has garnered significant acclaim as a recipient of the prestigious 2024 NAACOS Excellence Awards. This recognition highlights the organization's successful dedication to value-based care, shaping effective healthcare solutions tailored for patient needs. Leadership and Commitment to...

Continue Reading
SSCP Lager Bidco AB Shares Insights in Quarterly Report

Updated Category News Views 162

SSCP Lager Bidco AB Shares Insights in Quarterly Report Introduction to the Interim Report SSCP Lager Bidco AB (publ) recently released an interim report detailing the developments from April 1 to June 30 of a specific year, highlighting significant milestones and financial performance. Key Highlights of the Interim Report In this latest report, SSCP Lager Bidco AB...

Continue Reading
Important Corrections to ForFarmers N.V. Shareholder Meeting

Updated Category News Views 167

Update on the Resolutions of ForFarmers N.V. Annual General Meeting In a recent communication regarding the resolutions from the Annual General Meeting of Shareholders at ForFarmers N.V., some critical information was initially misstated. This announcement focuses on clarifying these details to ensure transparency and keep our stakeholders well-informed. Corrections to...

Continue Reading
Strong Increase in U.S. House Prices Despite Rising Rates

Updated Category News Views 90

U.S. House Prices Show Remarkable Growth The latest data reveals that U.S. single-family house prices experienced a strong increase in September, presenting challenges for many potential homeowners due to rising costs. This upward trend in the housing market is noteworthy, particularly as mortgage rates have begun to climb. Monthly Price Adjustments According to the...

Continue Reading
Upbeat BidCo Increases Buyout Offer Price for Believe's Shares

Updated Category News Views 208

Upbeat BidCo Raises Its Public Buyout Offer for Believe In an exciting development for investors, Upbeat BidCo has decided to increase its public buyout offer for Believe to 17.20 euros per share. This decision reflects a commitment to maximizing shareholder value while ensuring the future growth of Believe, a prominent digital music company. Significant Premium on the...

Continue Reading